Maciej Michał Kowalik

Dr. Maciej Michał Kowalik

orcid

Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 May 2020 in Cardiology Journal
Verified
Journal Article
Closed access
PDF file
MKMaciej M. Kowalik
Maciej M. Kowalik
PTPiotr Trzonkowski
Piotr Trzonkowski
MŁMagdalena Łasińska-Kowara
Magdalena Łasińska-Kowara
AMAndrzej Mital
Andrzej Mital
TSTomasz Smiatacz
Tomasz Smiatacz
MJMiłosz Jaguszewski
Miłosz Jaguszewski
The evidence on the pathophysiology of the novel coronavirus SARS-CoV-2 infection is rapidly growing. Understanding why some patients suffering from COVID-19 are getting so sick, while others are not, has become an informal imperative for researchers and clinicians around the globe. The answer to this question would allow rationalizing the fear surrounding this pandemic. Understanding of the pathophysiology of COVID-19 relies on an understanding of interplaying mechanisms, including SARS-CoV-2 virulence, human immune response, and complex inflammatory reactions with coagulation playing a major role. An interplay with bacterial co-infections, as well as the vascular system and microcirculation affected throughout the body should also be examined. More importantly, a comprehensive understanding of pathological mechanisms of COVID-19 will increase the efficacy of therapy and decrease mortality. Herewith, presented is the current state of knowledge on COVID-19: beginning from the virus, its transmission, and mechanisms of entry into the human body, through the pathological effects on the cellular level, up to immunological reaction, systemic and organ presentation. Last but not least, currently available and possible future therapeutic and diagnostic options are briefly commented on. The evidence on the pathophysiology of the novel coronavirus SARS-CoV-2 infection is rapidly growing. Understanding why some patients suffering from COVID-19 are getting so sick, while others are not, has become an informal imperative for researchers and clinicians around the globe. The answer to this question would allow rationalizing the fear surrounding this pandemic. Understanding of the pathophysiology of COVID-19 relies on an understanding of interplaying mechanisms, including SARS-CoV-2 virulence, human immune response, and complex inflammatory reactions with coagulation playing a major role. An interplay with bacterial co-infections, as well as the vascular system and microcirculation affected throughout the body should also be examined. More importantly, a comprehensive understanding of pathological mechanisms of COVID-19 will increase the efficacy of therapy and decrease mortality. Herewith, presented is the current state of knowledge on COVID-19: beginning from the virus, its transmission, and mechanisms of entry into the human body, through the pathological effects on the cellular level, up to immunological reaction, systemic and organ presentation. Last but not least, currently available and possible future therapeutic and diagnostic options are briefly commented on.

1 August 2011 in Journal of Cardiothoracic and Vascular Anesthesia
Verified
Journal Article
Closed access
PDF file
MKMaciej M. Kowalik
Maciej M. Kowalik
RLRomuald Lango
Romuald Lango
KKKatarzyna Klajbor
Katarzyna Klajbor
VMVioletta Musiał-Świa̢tkiewicz
Violetta Musiał-Świa̢tkiewicz
MKMagdalena Kołaczkowska
Magdalena Kołaczkowska
JRJan Rogowski
Jan Rogowski

1 June 2006 in Journal of Infection
Verified
Journal Article
Closed access
TSTomasz Smiatacz
Tomasz Smiatacz
MKMaciej Michal Kowalik
Maciej Michal Kowalik
MHMaria Hlebowicz
Maria Hlebowicz

1 April 2019 in Materials Science and Engineering: C
Verified
Journal Article
Closed access
MKMagdalena Kołaczkowska
Magdalena Kołaczkowska
PSPiotr Siondalski
Piotr Siondalski
MKMaciej Michał Kowalik
Maciej Michał Kowalik
RPRafał Pęksa
Rafał Pęksa
ADAldona Długa
Aldona Długa
PWPiotr Wilczek
Piotr Wilczek

7 December 2011 in International Journal of Laboratory Hematology
Verified
Journal Article
Closed access
PDF file
KLK. Lewandowski
K. Lewandowski
MKM. M. Kowalik
M. M. Kowalik
RPR. Pawlaczyk
R. Pawlaczyk
JRJ. Rogowski
J. Rogowski
AHA. Hellmann
A. Hellmann

14 March 2014 in Anaesthesiology Intensive Therapy
Verified
Journal Article
Open access
PDF file
PMPaweł Mroziński
Paweł Mroziński
RLRomuald Lango
Romuald Lango
ABAleksandra Biedrzycka
Aleksandra Biedrzycka
MKMaciej Michał Kowalik
Maciej Michał Kowalik
RPRafał Pawlaczyk
Rafał Pawlaczyk
JRJan Rogowski
Jan Rogowski
Background: Several studies have highlighted that volatile anaesthetics improve myocardial protection in cardiopulmonary bypass coronary surgery. However, the haemodynamic effect of desflurane in off-pump coronary surgery has not been clarified yet. Our study hypothesis was that desflurane-fentanyl anaesthesia could decrease myocardial injury markers and improve haemodynamics compared to propofol-fentanyl in patients undergoing off-pump coronary surgery. Methods: Design: Prospective, randomised open-lable study. Sixty elective patients with left ventricular ejection fraction above 30% received either desflurane (group D, n = 32) or propofol (group P, n = 28), in addition to fentanyl and vecuronium bromide anaesthesia for off-pump coronary surgery. Assessment of haemodynamic function included thermodilution continuous cardiac output and right ventricular end diastolic volume. Results: No significant differences in cardiac output, stroke volume and mean arterial pressure were noted between groups. The only observed difference in haemodynamic profile was that group D demonstrated improved stability, expressed as left ventricular stroke work index (LVSWI). Decrease in LVSWI after performing distal anastomoses was smaller in D compared to P (median value: –14.3 and –19.8 [g m m-2 beat-1]), respectively (P = 0.029). Oxygen uptake index (VO2I) and oxygen extraction ratio (OER) after skin incision were lower in D, while blood lactate concentration was slightly higher after surgery in D compared to P. The groups did not differ with respect to CK-MB and troponin I concentration. Conclusions: This study demonstrated no difference between desflurane and propofol anaesthesia for off-pump coronary surgery in major haemodynamic parameters, as well as in myocardial injury markers and the long-term outcome. However, the study indicated that desflurane might accelerate recovery of myocardial contractility, as assessed by LVSWI. Lower oxygen uptake and elevated lactate under desflurane anaesthesia indicated a discrete shift towards anaerobic metabolism. Clinical trial registration information: NCT00528515 (http://www.clinicaltrials.gov/ ct2/show/NCT00528515?term = NCT00528515&rank = 1) Background: Several studies have highlighted that volatile anaesthetics improve myocardial protection in cardiopulmonary bypass coronary surgery. However, the haemodynamic effect of desflurane in off-pump coronary surgery has not been clarified yet. Our study hypothesis was that desflurane-fentanyl anaesthesia could decrease myocardial injury markers and improve haemodynamics compared to propofol-fentanyl in patients undergoing off-pump coronary surgery. Methods: Design: Prospective, randomised open-lable study. Sixty elective patients with left ventricular ejection fraction above 30% received either desflurane (group D, n = 32) or propofol (group P, n = 28), in addition to fentanyl and vecuronium bromide anaesthesia for off-pump coronary surgery. Assessment of haemodynamic function included thermodilution continuous cardiac output and right ventricular end diastolic volume. Results: No significant differences in cardiac output, stroke volume and mean arterial pressure were noted between groups. The only observed difference in haemodynamic profile was that group D demonstrated improved stability, expressed as left ventricular stroke work index (LVSWI). Decrease in LVSWI after performing distal anastomoses was smaller in D compared to P (median value: –14.3 and –19.8 [g m m-2 beat-1]), respectively (P = 0.029). Oxygen uptake index (VO2I) and oxygen extraction ratio (OER) after skin incision were lower in D, while blood lactate concentration was slightly higher after surgery in D compared to P. The groups did not differ with respect to CK-MB and troponin I concentration. Conclusions: This study demonstrated no difference between desflurane and propofol anaesthesia for off-pump coronary surgery in major haemodynamic parameters, as well as in myocardial injury markers and the long-term outcome. However, the study indicated that desflurane might accelerate recovery of myocardial contractility, as assessed by LVSWI. Lower oxygen uptake and elevated lactate under desflurane anaesthesia indicated a discrete shift towards anaerobic metabolism. Clinical trial registration information: NCT00528515 (http://www.clinicaltrials.gov/ ct2/show/NCT00528515?term = NCT00528515&rank = 1)